90Y-J591

N/A

Report date: 2025/10/20 14:27:10

NME

Base Information

Drug Name90Y-J591

Drug Alias Nameyttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J59190Y-J591

ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-PSMA

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWeill Medical College of Cornell University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWeill Medical College of Cornell University

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A